glucagon has been researched along with Complications of Diabetes Mellitus in 136 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 89 (65.44) | 18.7374 |
1990's | 10 (7.35) | 18.2507 |
2000's | 20 (14.71) | 29.6817 |
2010's | 12 (8.82) | 24.3611 |
2020's | 5 (3.68) | 2.80 |
Authors | Studies |
---|---|
Anoop, S; Chowdhury, SD; Christina, F; Christudoss, P; Dasgupta, R; David, D; Jebasingh, FK; Kurian, ME; Lijesh, KU; Paul, TV; Seenivasan, S; Thomas, N; Varghese, G | 1 |
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
Giau, VV; Nguyen, TKO; Nguyen, TT; Nguyen, TTD; Ta, QTH | 1 |
Benchoula, K; Hwa, WE; Madhavan, P; Parhar, IS | 1 |
Anini, Y; Chappe, F; Chappe, V; Semaniakou, A | 1 |
Alejandro, R; Baidal, DA; Fabbri, A; Infante, M; Rickels, MR; Ricordi, C; Skyler, JS | 1 |
Eberhard, D; Heiss, C; Klüppel, C; Lammert, E; Mayatepek, E; Meissner, T; Mrugala, J; Welters, A; Wörmeyer, L | 1 |
Ranjan, A | 1 |
Aramandla, R; Babon, JAB; Balamurugan, AN; Bautista, A; Bottino, R; Brissova, M; Bush, WS; Dadi, PK; Dai, C; DeNicola, ME; Drumm, ML; Fayolle, C; Hart, NJ; Jacobson, DA; Kent, SC; MacDonald, PE; Poffenberger, G; Powers, AC; Prasad, N; Spigelman, AF; Thames, AH | 1 |
Freeman, J | 1 |
Andre, AD; Garibaldi, M; Newswanger, B; Prestrelski, S; Valentine, V | 1 |
Aoki, Y; Furuya, M; Hiyoshi, T; Kitaoka, H; Kuribayashi, N; Miyaoka, H; Murata, T; Naka, M; Oishi, M; Okazaki, K; Sakane, N; Shimizu, I; Sugimoto, M; Totsuka, Y; Waki, M; Yamada, K; Yamamoto, T; Yanagisawa, K | 1 |
Cryer, PE | 2 |
Avezza, F; Bianchi, R; Canta, A; Carozzi, V; Cavagnini, C; Cavaletti, G; Chiorazzi, A; Figliuzzi, M; Lauria, G; Lombardi, R; Marmiroli, P; Meregalli, C; Oggioni, N; Porretta-Serapiglia, C; Remuzzi, A; Sala, B | 1 |
Bendix Jensen, M; Carballo, D; Edwards, CN; Esdaile, DJ; Piché, C; Reno, FE; Török-Bathó, M; Triest, M | 1 |
Adnet, F; Alayrac, L; Barghout, M; Boudenia, K; Bounes, V; Chassery, C; Debaty, G; Egmann, G; Faucher, A; Fort, PA; Galinski, M; Hamdi, N; Lambert, Y; Lapostolle, F; Mokni, T; Peschanski, N; Ricard-Hibon, A; Roti, M; Safraou, M; Soulat, L | 1 |
Park, BH; Unger, RH; Wang, MY; Wang, ZV; Yu, X | 1 |
Brink, S; Hanas, R; Laffel, L; Likitmaskul, S; Liu, L; Maguire, AM; Olsen, B; Silink, M | 1 |
Niessen, SJ | 1 |
Endo, H; Miura, H; Nomura, H; Satake, S | 1 |
Bishop, AE; Bloom, SR; Khoo, B; Meeran, K; Roufosse, CA; Stanley, SA; Todd, JF | 1 |
FRENKEL, M; LANKAMP, HK; SCHOTTE, A | 1 |
Elahi, D; Mankad, S; Miske, G; Nikolaidis, LA; Shah, A; Shannon, RP; Sokos, GG | 1 |
Philips, JC; Radermecker, RP; Scheen, AJ | 1 |
Floyd, C; Harmon, C; Willoughby, DF | 1 |
Buchwald, A; Nolte, W; Raddatz, D; Ramadori, G; Rossbach, C; Scholz, KH | 1 |
Evert, AB | 1 |
Dziura, JD; Goldberg, PA; Hintz, EV; McCrimmon, RJ; Sherwin, RS; Weiss, R | 1 |
Adukauskiene, D; Blauzdyte, J | 1 |
Bhanot, S; Booten, SL; Cao, JX; Cox, AL; Finger, EA; Irizarry, AR; McKay, RA; Michael, MD; Monia, BP; Murray, SF; Showalter, AD; Siesky, AM; Sloop, KW; Zhang, HY | 1 |
Ciechanowicz, A; Frankow, M; Majkowska, L; Parczewski, M; Pilarska, K; Safranow, K; Stefanski, A | 1 |
Lawrence, GD; Macon, W; Montenegro, F; Pass, C | 1 |
Iser, JH; Johnson, RD; Kune, GA; Larkins, RG; Roberts-Thomson, IC | 1 |
Block, M; Bloom, SR; Hafez, GR; Lloyd, RV; Mack, E; Warner, TF | 1 |
Boden, G; Hoeldtke, RD | 1 |
Fukushima, H; Uzawa, H; Yamaguchi, K | 1 |
Christensen, NJ; Faber, OK; Hilsted, J; Krarup, T; Madsbad, S; Sestoft, L; Tronier, B | 1 |
Heinke, P; Ratzmann, KP; Schulz, B; Witt, S; Ziegler, M | 1 |
Atkinson, AB; Buchanan, KD; Hadden, DR; Trimble, ER | 1 |
Garrett, BN; Kaplan, NM; Raskin, P | 1 |
Marliss, EB; Nakhooda, AF; Sole, MJ | 1 |
Chesney, RW; Colle, E; Goldman, H; Kaplan, BS; McInnes, RR; Scriver, CR; Teitel, D | 1 |
Boden, G; Hoeldtke, RD; Owen, OE; Reichard, GA; Rezvani, I | 1 |
DeLawter, DE | 1 |
Baumgartner, R; Blum, D; De Prez, C; Dorchy, H; Fowler, B; Heimann, P; Kumps, A; Mardens, Y; Mouraux, T; Vamos, E | 1 |
Matthews, DE; Petrides, AS; Schulze-Berge, D; Strohmeyer, G; Vogt, C | 1 |
Bovo, P; Brunori, MP; Cavallini, G; Cigolini, M; Di Francesco, V; Frulloni, L; Rigo, L; Rossi, F; Tasini, E; Vaona, B | 1 |
Holst, JJ; Koch, C; Lanng, S; Nerup, J; Orskov, C; Røder, ME; Thorsteinsson, B | 1 |
Alberti, KG; Bhat, DS; Hockaday, TD; Naik, SS; Orskov, H; Raut, KN; Sardesai, BS; Shelgikar, KM; Yajnik, CS | 1 |
Adrian, TE; Fruin, AB; Herrington, MK; Larsson, J; Permert, J; Tatemoto, K; von Schenck, H | 1 |
Goulas, S; Kruszynska, YT; McIntyre, N; Wollen, N | 1 |
Akai, H; Chiba, M; Hinokio, Y; Hirai, A; Hirai, M; Kasuga, S; Ohtomo, M; Satoh, Y; Suzuki, S; Toyota, T | 1 |
Cabot, LB; Jowett, NI | 1 |
Sélam, JL | 1 |
Brändle, M; Lehmann, R; Maly, FE; Schmid, C; Spinas, GA | 1 |
Hietaniemi, K; Kiviluoto, T; Mäkimattila, S; Timonen, T; Yki-Järvinen, H | 1 |
Barazzoni, R; Kiwanuka, E; Tessari, P | 1 |
Tkacs, NC | 1 |
Jandrain, B; Lefèbvre, PJ; Paquot, N; Scheen, AJ | 1 |
Ammann, R; Hedinger, C; Säuberli, H; Woodtli, W; Zimmermann, K | 1 |
Grieder, MH; Kipnis, DM; Leichter, SB; Pagliara, AS; Pohl, S; Rosai, J | 1 |
Mayr, WR; Tragl, KH | 1 |
De Nutte, N; De Vroede, M; Gepts, W; Pipeleers, D; Somers, G | 1 |
Ackermann-Schopf, C; Metz, J; Röckl, H | 1 |
Berczeller, PH; Shupack, JL; Stevens, DM | 1 |
Bersani, G; Betterle, C; Del Prete, GF; Garotti, C; Nosadini, R; Tiengo, A | 1 |
Aldor, TA; Baetens, D; Collins, SM; Conlon, JM; Davis, GR; Krejs, GJ; McCarthy, DM; Orci, L; Raskin, P; Ravazzola, M; Rubenstein, A; Unger, RH | 1 |
Binder, C; Faber, OK; Pyke, DA; Smith, RB; Watkins, PJ | 1 |
Kitabchi, AE; Kraus, AP; Morrison, JC; Schneider, JM | 1 |
Berchtold, P; Berger, M; Cüppers, HJ; Gonvers, JJ; Hofstetter, JR; Muller, WA; Renold, AE; Strohmeyer, G | 1 |
Aeberhard, P; Berger, M; Krebs, A; Studer, PP; Teuscher, A | 1 |
Arrigo, F; Consolo, F; Di Tommaso, G; Trifirì, A | 1 |
Altman, JJ; Fiet, J; Passa, P; Zygelman, M | 1 |
Kai, Y; Koseki, S; Maekawa, N; Ohneda, A; Saito, Y | 1 |
Bloom, SR; Malins, JM; Walsh, CH | 1 |
Spellacy, WN | 1 |
Bersani, G; Betterle, C; Del Prete, G; Fedele, D; Nosadini, R; Tiengo, A | 1 |
Kidson, W | 1 |
Goto, A; Kawamura, K; Kawanishi, K; Nishina, Y; Okada, S | 1 |
Barany, FR; Linde, J; Nilsson, LH | 1 |
Thomas, ID | 1 |
Canivet, J; Carpentier, JL; Lefebvre, PJ; Luyckx, AS; Passa, P | 1 |
Avram, MM; Carter, AC; Delano, BG; Frank, W; Friedman, EA; Manis, T; Rao, TK; Saxena, AK | 1 |
Baetens, D; Dobbs, R; Faloona, G; Orci, L; Sakurai, H; Sasaki, H; Unger, R; Valverde, I | 1 |
Holst, JJ | 1 |
Cohen, GN; Fisherman, EW | 1 |
Richards, AJ | 1 |
Holst, JJ; Jonsson, L; Pedersen, NB; Thomsen, K | 1 |
Binder, HJ; Donowitz, M; Felig, P; Hendler, R; Spiro, HM | 1 |
Broekhoven-Schokker, S; Hülsmann, WC; Schoonderwoerd, K; Stam, H | 1 |
Ball, P | 1 |
Farkas, G; Lászik, Z; Ormos, J; Pap, A | 1 |
Barnett, AH; Chiodini, PL; Farrell, ID; Geddes, AM; Gilbert, J; Odugbesan, O; Toop, MJ | 1 |
Kawakami, K | 1 |
Viberti, GC; Wiseman, MJ | 1 |
Djordjević, P; Djurić, DS; Micić, D; Mićić, J; Nesović, M; Popović, V | 1 |
Duncan, LJ; MacCuish, AC; Munro, JF | 1 |
Dahlgren, S; Grimelius, L; Lundquist, G; Parrow, A; Petersson, B | 1 |
Voskresenskiĭ, ON | 1 |
Sweet, RD | 1 |
Lenti, G | 1 |
Amigues, N; Chimenes, H; Darnis, F; Delorme, ML; Mossé, A | 1 |
Langr, F; Lomský, R; Vortel, V | 1 |
Guinet, P; Magnien, JM; Mornex, R; Tourniaire, J; Veyrat, A | 1 |
Drash, A | 2 |
Fisher, AA; Poliak, RI | 1 |
Bloom, SR; Cox, B; Mallinson, CN | 1 |
Hâncu, N; Tecuceanu, T | 1 |
Warin, AP | 1 |
Batistoni, GA; Besser, GM; Bloom, SR; Coy, DH; Hall, R; Hanssen, KF; Kastin, AJ; Kastrup, KW; McNeilly, AS; Mortimer, CH; Schally, AV; Thorner, MO | 1 |
Bruni, B | 1 |
Faloona, GR; Rocha, DM; Santeusanio, F; Unger, RH | 1 |
Assan, R; Tiengo, A | 1 |
Mosin, VI | 1 |
Laube, H; Pfeiffer, EF | 1 |
Beisel, WR | 1 |
Crepaldi, G; Federspil, G; Muggeo, M; Scandellari, C; Tiengo, A; Trisotto, A | 1 |
Genuth, SM | 1 |
Emmer, M; Gorden, P; Roth, J | 1 |
Levine, R | 1 |
Manns, JG; Martin, CL | 1 |
Assan, R; Tchobroutsky, G; Tiengo, A | 1 |
Aepli, R; Friedemann, M; Perrelet, C | 1 |
Schaetz, A | 1 |
Donnell, GN; Frasier, SD; Kogut, MD; Ling, SM | 1 |
Carneiro de Moura, M; Ginestal Cruz, A | 1 |
Forette, B | 1 |
Beringer von, A; Geyer, G; Mösslacher, H; Tragl, KH; Waldhäusl, W | 1 |
Crockford, PM; Hazzard, WR; Williams, RH | 1 |
Nishikawa, M; Okuno, G; Shinji, Y; Tsujii, T; Yoshinaga, T | 1 |
Steigerwaldt, F | 1 |
Franchimont, C; Gerard, J; Lapiere, CM; Luyckx, AS; Pierard, GE | 1 |
25 review(s) available for glucagon and Complications of Diabetes Mellitus
Article | Year |
---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blood Glucose; Brain; Diabetes Complications; Diabetes Mellitus; Disease Susceptibility; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Signal Transduction | 2020 |
CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Diabetes Complications; Diabetes Mellitus; Drug Delivery Systems; Glucagon; Humans; Hypoglycemic Agents; Treatment Outcome | 2021 |
Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 1; Glucagon; Humans; Insulin; Insulin Infusion Systems; Islet Amyloid Polypeptide; Pancreas, Artificial | 2021 |
NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.
Topics: Animals; Apoptosis; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Drug Design; Drug Resistance, Multiple; Drugs, Investigational; Glucagon; Glucagon-Secreting Cells; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Neuralgia; Receptors, N-Methyl-D-Aspartate | 2017 |
Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 1; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin | 2018 |
Management of hypoglycemia in older adults with type 2 diabetes.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Blood Glucose; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Continuity of Patient Care; Dementia; Diabetes Complications; Diabetes Mellitus, Type 2; Glucagon; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Patient-Centered Care; Practice Guidelines as Topic; Risk Factors; Time Factors | 2019 |
Mechanisms of hypoglycemia-associated autonomic failure in diabetes.
Topics: Brain; Diabetes Complications; Diabetes Mellitus; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Pure Autonomic Failure; Sulfonylurea Compounds | 2013 |
Sick day management in children and adolescents with diabetes.
Topics: Adolescent; Blood Glucose; Child; Diabetes Complications; Glucagon; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Infections; Insulin; Ketones; Sick Leave | 2009 |
[Acute complications due to diabetes mellitus: Hypoglycemic coma].
Topics: Acute Disease; Coma; Diabetes Complications; Diagnosis, Differential; Energy Metabolism; Glucagon; Glucose; Humans; Hypoglycemia; Prognosis; Sympathetic Nervous System | 2002 |
A lesson in early morning hyperglycemia.
Topics: Blood Glucose Self-Monitoring; Circadian Rhythm; Diabetes Complications; Dose-Response Relationship, Drug; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Metformin; Somatomedins; Time Factors | 2004 |
Managing hypoglycemia in the school setting.
Topics: Algorithms; Blood Glucose; Blood Glucose Self-Monitoring; Causality; Child; Decision Trees; Diabetes Complications; Dietary Carbohydrates; Emergencies; First Aid; Glucagon; Glucose; Humans; Hypoglycemia; Nurse's Role; Nursing Assessment; School Nursing; Severity of Illness Index | 2005 |
[Causes, diagnosis, and treatment of hypoglycemia].
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents; Blood Glucose; Child; Diabetes Complications; Diagnosis, Differential; Female; Glucagon; Glucose; Glucose Tolerance Test; Homeostasis; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin Secretion; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms | 2006 |
Hypoglycemia unawareness.
Topics: Adult; Blood Glucose; Diabetes Complications; Epinephrine; Female; Glucagon; Gluconeogenesis; Glycolysis; Humans; Hypoglycemia; Information Services; Internet; Patient Education as Topic; Risk Factors; Self Care | 2002 |
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management].
Topics: Absorption; Cardiovascular Diseases; Diabetes Complications; Dietary Carbohydrates; Dietary Fiber; Glucagon; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Kinetics; Postprandial Period; Risk Factors | 2002 |
Carbohydrate metabolism in male infertility and female fertility-control patients.
Topics: Candidiasis, Vulvovaginal; Carbohydrate Metabolism; Contraceptives, Oral; Diabetes Complications; Diabetes Mellitus; Erectile Dysfunction; Estrogens; Ethynodiol Diacetate; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Infertility, Male; Male; Norethindrone; Norgestrel; Pregnancy; Proinsulin; Pyridoxine | 1976 |
[Glucagon syndrome].
Topics: Anemia; Diabetes Complications; Emaciation; Erythema; Glucagon; Humans; Pancreatic Neoplasms; Syndrome | 1975 |
The kidney in diabetes: significance of the early abnormalities.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dietary Proteins; Glomerular Filtration Rate; Glucagon; Growth Hormone; Hemodynamics; Humans; Hypertrophy; Insulin; Kidney; Prognosis; Proteinuria; Regional Blood Flow; Ultrafiltration | 1986 |
[Pancreatic hormones and arteriosclerosis].
Topics: Aging; Animals; Arteriosclerosis; Blood Proteins; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dogs; Fatty Acids; Fatty Liver; Glucagon; Guinea Pigs; Hypercholesterolemia; Insulin; Insulin Secretion; Lipotropic Agents; NADP; Obesity; Pancreatectomy; Phosphatidylcholines; Rabbits; Rats; Sterols; Tissue Extracts | 1967 |
Diabetes mellitus in childhood: a review.
Topics: Adrenocorticotropic Hormone; Affective Symptoms; Age Factors; Blood Glucose; Catecholamines; Child; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Coma; Diabetic Ketoacidosis; Diet Therapy; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hypoglycemic Agents; Infusions, Parenteral; Insulin; Lipid Metabolism; Obesity; Prediabetic State; United States | 1971 |
[Insulin hypoglycemia and its effect on the stomach].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Blood Glucose; Diabetes Complications; Gastric Juice; Gastric Mucosa; Glucagon; Humans; Insulin; Peptic Ulcer; Stomach | 1972 |
[Endocrine apparatus of the pancreas and the stomach].
Topics: Animals; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Gastric Juice; Gastric Mucosa; Gastrointestinal Motility; Glucagon; Humans; Hyperinsulinism; Insulin; Islets of Langerhans; Pancreatic Neoplasms; Peptic Ulcer; Stomach; Stomach Ulcer; Zollinger-Ellison Syndrome | 1972 |
Obesity and diabetes mellitus.
Topics: Adipose Tissue; Age Factors; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Complications; Diabetes Mellitus; Diet Therapy; Dietary Carbohydrates; Glucagon; Glucose Tolerance Test; Humans; Hyperlipidemias; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Pancreas; Perfusion; Proinsulin; Rats; Time Factors; Tolbutamide; Triglycerides | 1974 |
Diabetes in association with other endocrine disorders.
Topics: Acromegaly; Cushing Syndrome; Diabetes Complications; Endocrine System Diseases; Glucagon; Glucose; Growth Hormone; Humans; Hyperthyroidism; Hypopituitarism; Hypothyroidism; Insulin; Insulin Secretion; Pheochromocytoma | 1971 |
New horizons in our knowledge of diabetes mellitus.
Topics: Animals; Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Sulfonylurea Compounds | 1971 |
7 trial(s) available for glucagon and Complications of Diabetes Mellitus
Article | Year |
---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Glucose; Combined Modality Therapy; Diabetes Complications; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Pilot Projects; Safety; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2004 |
Ketosis resistance in fibrocalculous pancreatic diabetes: II. Hepatic ketogenesis after oral medium-chain triglycerides.
Topics: Adipose Tissue; Administration, Oral; Adult; Blood Glucose; C-Peptide; Carnitine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Fatty Acids; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Ketones; Liver; Male; Triglycerides | 1997 |
The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.
Topics: Adult; C-Peptide; Coenzymes; Deafness; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; DNA, Mitochondrial; Family Health; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hearing; Humans; Lactic Acid; Male; Middle Aged; Mothers; Point Mutation; Time Factors; Treatment Outcome; Ubiquinone | 1998 |
Sulbactam/ampicillin: effects on glucose metabolism in diabetics with soft tissue infection.
Topics: Ampicillin; Bacterial Infections; Blood Glucose; C-Peptide; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Floxacillin; Glucagon; Humans; Middle Aged; Penicillanic Acid; Sulbactam; Time Factors | 1985 |
Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Glucose; Child; Child, Preschool; Diabetes Complications; Diabetic Coma; Glucagon; Glucose; Humans; Hypoglycemia; Infant; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Mannitol; Middle Aged; Time Factors | 1970 |
[Cardiological use of glucagon-zinc-protamine in diabetes].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Diabetes Complications; Female; Glucagon; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Protamines; Shock, Cardiogenic; Zinc | 1972 |
105 other study(ies) available for glucagon and Complications of Diabetes Mellitus
Article | Year |
---|---|
Comprehensive evaluation of patterns of hypoglycemia unawareness (HUA) and glycemic variability (GV) in patients with fibrocalculous pancreatic diabetes (FCPD): A cross-sectional study from South India.
Topics: Blood Glucose; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose; Humans; Hypoglycemia; India | 2022 |
VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD).
Topics: Animals; Blood Glucose; Cystic Fibrosis; Diabetes Complications; Glucagon; Homozygote; Insulin; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Pancreas; Vasoactive Intestinal Peptide | 2021 |
Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Topics: Adult; Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Complications; Diabetes Mellitus; Female; Gene Deletion; Glucagon; Humans; Inflammation; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mutation | 2018 |
Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation.
Topics: Adolescent; Adult; Caregivers; Diabetes Complications; Drug Delivery Systems; Emergency Responders; Ergonomics; Female; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Injections; Male; Young Adult | 2019 |
Glucagon underutilized among type 1 diabetes mellitus patients in Japan.
Topics: Adult; Aged; Confidence Intervals; Diabetes Complications; Diabetes Mellitus, Type 1; Drug Utilization; Female; Gastrointestinal Agents; Glucagon; Health Knowledge, Attitudes, Practice; Humans; Hypoglycemia; Japan; Logistic Models; Male; Middle Aged; Odds Ratio; Surveys and Questionnaires | 2013 |
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Complications; Glucagon; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Male; Neural Conduction; Nociception; Pain Threshold; Proteinuria; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Thiobarbituric Acid Reactive Substances | 2013 |
Needle-free nasal delivery of glucagon for treatment of diabetes-related severe hypoglycemia: toxicology of polypropylene resin used in delivery device.
Topics: Administration, Intranasal; Animals; Cell Line; Cell Survival; Diabetes Complications; Diabetes Mellitus; Drug Delivery Systems; Edema; Erythema; Glucagon; Guinea Pigs; Hypoglycemia; Insulin; Mice; Needles; Polypropylenes; Rabbits; Skin | 2016 |
Diabetes education of patients and their entourage: out-of-hospital national study (EDUCATED 2).
Topics: Adult; Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Emergency Medical Services; Female; France; Glucagon; Glycated Hemoglobin; Health Education; Health Literacy; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Social Support | 2017 |
Making insulin-deficient type 1 diabetic rodents thrive without insulin.
Topics: Alloxan; Animals; Diabetes Complications; Diabetes Mellitus, Type 1; Down-Regulation; Glucagon; Insulin; Insulin-Like Growth Factor I; Liver; Mice; Rats; Signal Transduction; STAT3 Transcription Factor; Streptozocin | 2008 |
Glucagon: are we missing a (life-saving) trick?
Topics: Animals; Cat Diseases; Cats; Diabetes Complications; Dog Diseases; Dogs; Glucagon; Hormones; Humans; Hypoglycemia; Insulin | 2012 |
A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes.
Topics: Blood Glucose; Carcinoid Tumor; Diabetes Complications; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Hypoglycemia; Hysterectomy; Middle Aged; Ovarian Neoplasms; Peptide Fragments; Protein Precursors; Somatostatin | 2003 |
[Acute glycogen infiltration of the liver in diabetes mellitus. 2. The effects of glucagon therapy].
Topics: Diabetes Complications; Diabetes Mellitus; Glucagon; Glycogen; Humans; Liver Diseases | 1960 |
[Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association].
Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Exenatide; Glucagon; Glucagon-Like Peptide 1; Heptanoic Acids; Humans; Islets of Langerhans Transplantation; Peptide Fragments; Peptides; Protein Precursors; Pyrroles; Venoms | 2004 |
Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Female; Glucagon; Glycated Hemoglobin; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic | 2005 |
Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure.
Topics: Adolescent; Adult; Autonomic Nervous System; Cushing Syndrome; Diabetes Complications; Epinephrine; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Infusions, Intravenous | 2006 |
Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes.
Topics: Adrenal Glands; Animals; Autonomic Nervous System Diseases; Corticotropin-Releasing Hormone; Diabetes Complications; Diabetes Mellitus; Glucagon; Humans; Hypoglycemia; Insulin; Rats; Urocortins; Ventromedial Hypothalamic Nucleus | 2006 |
Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.
Topics: Acidosis, Lactic; Animals; Antiporters; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Type 2; Glucagon; Glucose-6-Phosphatase; Glycogen; Glycogen Storage Disease; Hyperlipidemias; Hyperuricemia; Hypoglycemia; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Monosaccharide Transport Proteins; Oligoribonucleotides, Antisense; RNA, Messenger | 2007 |
The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.
Topics: Aged; ATP-Binding Cassette Transporters; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Injections, Intravenous; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide; Potassium Channels; Potassium Channels, Inwardly Rectifying; Prevalence; Receptors, Drug; Stroke; Sulfonylurea Receptors; Time Factors | 2007 |
Metastatic glucagonoma. improvement after surgical debulking.
Topics: Adenoma, Islet Cell; Diabetes Complications; Erythema; Glucagon; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Syndrome | 1980 |
The glucagonoma syndrome: an unusual skin rash associated with diarrhoea and diabetes.
Topics: Adenoma, Islet Cell; Diabetes Complications; Diarrhea; Erythema; Glucagon; Humans; Male; Middle Aged; Pancreatic Neoplasms; Syndrome | 1981 |
Glucagonomas. Ultrastructure and immunocytochemistry.
Topics: Adenoma, Islet Cell; Aged; Diabetes Complications; Female; Glucagon; Glucagonoma; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Microscopy, Electron; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide | 1983 |
Making intensified insulin treatment safer.
Topics: Diabetes Complications; Diabetes Mellitus; Epinephrine; Glucagon; Humans; Hypoglycemia; Insulin | 1983 |
A report on a case of association of diabetes mellitus and hyperthyroidism with no deterioration of diabetic control-with special regard to serial changes in glucose tolerance and glucoregulatory hormones.
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperthyroidism; Insulin; Insulin Secretion; Middle Aged | 1982 |
Hormonal, metabolic and cardiovascular responses to hypoglycaemia in Type 1 (insulin-dependent) diabetes with and without residual B cell function.
Topics: Adult; Diabetes Complications; Diabetes Mellitus; Epinephrine; Glucagon; Growth Hormone; Hemodynamics; Hormones; Humans; Hydrocortisone; Hypoglycemia; Islets of Langerhans; Male | 1982 |
Pancreatic glucagon response to glucose in hyperlipoproteinaemia with and without abnormalities in carbohydrate metabolism.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Insulin; Insulin Secretion; Male; Obesity | 1980 |
Plasma glucagon and insulin concentrations in acromegaly.
Topics: Acromegaly; Adolescent; Adult; Aged; Arginine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged | 1980 |
Metoprolol in diabetes mellitus: effect on glucose homeostasis.
Topics: Aged; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Homeostasis; Humans; Hydrochlorothiazide; Hypertension; Insulin; Male; Metoprolol; Middle Aged; Propanolamines; Renin | 1980 |
Adrenergic regulation of glucagon and insulin secretion during immobilization stress in normal and spontaneously diabetic BB rats.
Topics: Adrenal Glands; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Immobilization; Insulin; Male; Phentolamine; Propranolol; Rats; Stress, Physiological | 1981 |
Metabolic abnormalities in the idiopathic Fanconi syndrome: studies of carbohydrate metabolism in two patients.
Topics: Adolescent; Adult; Blood Glucose; Carbohydrate Metabolism; Child; Child, Preschool; Diabetes Complications; Ethanol; Fanconi Syndrome; Fructose; Galactose; Glucagon; Humans; Insulin; Male; Tolbutamide | 1981 |
Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones.
Topics: Blood Glucose; Diabetes Complications; Epinephrine; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Middle Aged; Norepinephrine | 1981 |
One minute with diabetes.
Topics: Adult; Diabetes Complications; Glucagon; Humans; Hypoglycemia; Male | 1982 |
Congenital absence of insulin cells in a neonate with diabetes mellitus and mutase-deficient methylmalonic acidaemia.
Topics: Autopsy; Cytoplasmic Granules; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Infant, Newborn; Insulin; Islets of Langerhans; Metabolism, Inborn Errors; Methylmalonic Acid; Methylmalonyl-CoA Mutase; Microscopy, Electron; Pancreas; Synaptophysin | 1993 |
Glucose resistance contributes to diabetes mellitus in cirrhosis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Diabetes Mellitus; Drug Resistance; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Lactates; Lactic Acid; Liver; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Oxidation-Reduction | 1993 |
Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance.
Topics: Alcoholism; Blood Glucose; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Pancreatitis | 1993 |
Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Topics: Administration, Oral; Adult; C-Peptide; Cystic Fibrosis; Diabetes Complications; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Hormones; Humans; Injections, Intravenous; Insulin; Intestinal Mucosa; Intestines; Male; Middle Aged; Pancreas; Pancreatic Polypeptide; Peptide Fragments; Proinsulin; Protein Precursors; Time Factors | 1993 |
Islet hormone secretion in pancreatic cancer patients with diabetes.
Topics: Adenocarcinoma; Aged; Diabetes Complications; Diabetes Mellitus; Fasting; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Islets of Langerhans; Male; Middle Aged; Pancreatic Hormones; Pancreatic Neoplasms | 1997 |
Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Topics: Adult; Aged; Arginine; Basal Metabolism; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Liver Cirrhosis, Alcoholic; Middle Aged; Secretory Rate | 1998 |
Diabetic hypoglycaemia and the dental patient.
Topics: Dental Care for Chronically Ill; Diabetes Complications; Emergency Treatment; Glucagon; Humans; Hypoglycemia; Injections, Intramuscular; Insulin | 1998 |
[Acute metabolic complications of diabetes mellitus (ketoacidosis, hypoglycemia, hyperosmolarity, lactic acidosis). Etiology, physiopathology, diagnosis, emergency treatment of ketoacidosis with drug posology].
Topics: Acidosis, Lactic; Aged; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diagnosis, Differential; Emergencies; Glucagon; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Hypoglycemia; Insulin; Models, Biological | 2000 |
Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Deafness; Diabetes Complications; Diabetes Mellitus; DNA, Mitochondrial; Female; Genomic Imprinting; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Nuclear Family; Pedigree; Point Mutation; Reference Values; RNA; RNA, Mitochondrial; RNA, Transfer, Leu; Time Factors | 2001 |
In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
Topics: Adenocarcinoma; Amyloid; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glucose Transporter Type 2; Humans; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Predictive Value of Tests; Reference Values | 2001 |
Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Food; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Kinetics; Lactic Acid; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Splanchnic Circulation | 2001 |
[Glucagon producing adenomatosis of Islands of Langerhans with polyendocrine symptoms].
Topics: Adipose Tissue; Adrenal Cortex; Adrenal Glands; Adult; Calcinosis; Cholecystectomy; Cushing Syndrome; Diabetes Complications; Gastrins; Glucagon; Humans; Hyperplasia; Islets of Langerhans; Male; Multiple Endocrine Neoplasia; Necrosis; Obesity; Pancreas; Zollinger-Ellison Syndrome | 1976 |
Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma.
Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Epinephrine; Female; Glucagon; Glucose; Glucose Tolerance Test; Glucosephosphate Dehydrogenase; Hexokinase; Humans; Insulin; Middle Aged; Pancreatic Neoplasms; Phenoxybenzamine; Staining and Labeling | 1975 |
Familial islet-cell adenomatosis.
Topics: Adenoma, Islet Cell; Adult; Blood Glucose; Diabetes Complications; Female; Glucagon; HLA Antigens; Humans; Insulin; Male; Middle Aged; Multiple Endocrine Neoplasia; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Pedigree; Tolbutamide | 1977 |
Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
Topics: C-Peptide; Diabetes Complications; Female; Glucagon; Humans; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioimmunoassay; Somatostatin; Streptozocin; Tolbutamide | 1979 |
[Staphylodermia superficialis circinata. The 5th obligatory cutaneous paraneoplasia].
Topics: Adult; Anemia; Carcinoma, Hepatocellular; Colonic Neoplasms; Diabetes Complications; Female; Glossitis; Glucagon; Humans; Liver Neoplasms; Neoplasm Metastasis; Pancreatic Neoplasms; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 1977 |
The glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Adult; Diabetes Complications; Female; Glucagon; Humans; Pancreatic Neoplasms; Skin Diseases; Syndrome | 1978 |
Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies.
Topics: Adult; Aged; Arginine; Autoantibodies; Autoimmune Diseases; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Male; Middle Aged | 1977 |
Somatostatinoma syndrome. Biochemical, morphologic and clinical features.
Topics: C-Peptide; Celiac Disease; Cholelithiasis; Diabetes Complications; Glucagon; Hormones, Ectopic; Humans; Hypothalamus; Islets of Langerhans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Pituitary Gland; Radioimmunoassay; Somatostatin; Syndrome | 1979 |
C-peptide response to glucagon in diabetics with and without complications.
Topics: Adult; C-Peptide; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Peptides | 1979 |
The prevalence of diabetes mellitus in sickle cell hemoglobinopathies.
Topics: Anemia, Sickle Cell; Black People; Blood Glucose; Diabetes Complications; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Pregnancy; Pregnancy in Diabetics; Thalassemia | 1979 |
Plasma glucagon in diabetes of haemochromatosis: too low or too high?
Topics: Arginine; Blood Glucose; Cross Reactions; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Hemochromatosis; Humans; Immunoassay; Insulin; Male; Middle Aged; Molecular Weight | 1979 |
[The course of diabetes and clinical findings in glucagonoma].
Topics: Aged; Anemia; Blood Glucose; Body Weight; Diabetes Complications; Exanthema; Glucagon; Humans; Male; Pancreatic Neoplasms; Splenectomy; Stomatitis | 1979 |
[Hyperlipemia and carbohydrate metabolism: effects of glucagon in primary and secondary hypertriglyceridemia].
Topics: Carbohydrate Metabolism; Diabetes Complications; Female; Glucagon; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides | 1977 |
[Familial idiopathic haemochromatosis with diabetes. Study of glucagon and growth hormone secretions (author's transl)].
Topics: Adult; Aged; Arginine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Growth Hormone; Hemochromatosis; Humans; Insulin; Male; Middle Aged | 1978 |
Secondary diabetic retinopathy in chronic pancreatitis.
Topics: Adult; Aged; Arginine; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreatitis | 1978 |
Diabetes mellitus in idiopathic haemochromatosis.
Topics: Aged; Blood Glucose; Diabetes Complications; Glucagon; Hemochromatosis; Humans; Middle Aged; Pancreas | 1978 |
[The secretion of glucagon and insulin in patients with anti-pancreatic-islet antibodies (ICA +) (proceedings)].
Topics: Autoimmune Diseases; Diabetes Complications; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans | 1976 |
The emergency management of the diabetic at home.
Topics: Diabetes Complications; Diabetes Mellitus; Diabetic Ketoacidosis; Emergencies; First Aid; Glucagon; Glucose; Home Nursing; Humans; Hyperglycemia; Hypoglycemia; Insulin; Vomiting | 1976 |
Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies.
Topics: Autoantibodies; C-Peptide; Cyclophosphamide; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Immunosuppressive Agents; Insulin; Insulin Antibodies; Insulin Resistance; Middle Aged; Prednisolone; Receptor, Insulin; Sjogren's Syndrome | 1977 |
Diabetes and hypoglycemia in chronic pancreatitis.
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Diabetes Complications; Female; Glucagon; Glycosuria; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Pancreatitis; Retrospective Studies | 1977 |
Hypoglycaemia.
Topics: Diabetes Complications; Glucagon; Glucose; Humans; Hypoglycemia | 1977 |
Glucagon secretion in diabetic patients with idiopathic haemochromatosis.
Topics: Adult; Aged; Arginine; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Hemochromatosis; Humans; Kinetics; Male; Middle Aged | 1977 |
Uremic hyperlipoproteinemia: correlation with residual renal function and duration of maintenance hemodialysis.
Topics: Androgens; Cholesterol; Creatinine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Growth Hormone; Humans; Hyperlipidemias; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors; Triglycerides | 1977 |
Glucagon: role in the hyperglycemia of diabetes mellitus.
Topics: Animals; Arginine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dogs; Glucagon; Growth Hormone-Releasing Hormone; Hyperglycemia; Insulin; Oligopeptides; Pancreatectomy | 1975 |
Intrinsic asthma associated with diabetes mellitus; abnormal vascular response and glucose tolerance tests.
Topics: Aspirin; Asthma; Blood Coagulation Tests; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Diabetes Complications; Drug Hypersensitivity; Fructose; Galactose; Glucagon; Glucose; Glucose Tolerance Test; Histidine; Humans; Insulin; Iodides; Polysorbates; Rhinitis, Allergic, Seasonal; Skin Tests | 1975 |
Letter: Glucagon and pseudogout.
Topics: Chondrocalcinosis; Diabetes Complications; Glucagon; Humans | 1975 |
[Glucagon syndrome].
Topics: Aged; Anemia; Diabetes Complications; Erythema; Female; Glucagon; Humans; Leg Dermatoses; Male; Pancreatic Neoplasms; Syndrome | 1975 |
Glucagon secretion in acute and chronic pancreatitis.
Topics: Acute Disease; Adult; Aged; Alanine; Amylases; Chronic Disease; Diabetes Complications; Female; Glucagon; Humans; Insulin; Middle Aged; Pancreatitis | 1975 |
Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes.
Topics: Acyltransferases; Animals; Biological Transport; Coronary Disease; Cytosol; Diabetes Complications; Diabetes Mellitus; Diacylglycerol O-Acyltransferase; Fatty Acids; Glucagon; In Vitro Techniques; Kinetics; Magnesium; Male; Microsomes; Myocardium; Oleic Acids; Phosphatidate Phosphatase; Phosphoric Monoester Hydrolases; Rats | 1990 |
The diabetic patient. Regulating serum glucose levels intraoperatively.
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Electrolytes; Fluid Therapy; Glucagon; Glucose; Humans; Infusions, Parenteral; Insulin; Intraoperative Care; Perioperative Nursing; Stress, Physiological; Surgical Procedures, Operative | 1986 |
Endocrine pancreas in chronic pancreatitis. A qualitative and quantitative study.
Topics: Adult; Cell Count; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Middle Aged; Pancreas; Pancreatitis; Somatostatin | 1989 |
[Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Topics: C-Peptide; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Liver Cirrhosis; Middle Aged; Pancreatic Hormones; Pancreatic Polypeptide; Radioimmunoassay | 1988 |
Chronic bromocriptine treatment and glucose intolerance in acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged | 1985 |
Staining reactions in an islet cell carcinoma of - 2 -type.
Topics: Adenoma, Islet Cell; Cell Transformation, Neoplastic; Cytoplasmic Granules; Diabetes Complications; Female; Glucagon; Humans; Insulin; Insulin Secretion; Microscopy, Electron; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Radioimmunoassay; Staining and Labeling | 1971 |
A dermatosis specifically associated with a tumour of pancreatic alpha cells.
Topics: Blister; Blood Glucose; Body Weight; Diabetes Complications; Female; Glucagon; Glucose; Glucose Tolerance Test; Glyburide; Glycosuria; Humans; Immunoglobulin A; Immunoglobulin M; Insulin; Keratosis; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Skin Diseases; Splenectomy; Stress, Psychological | 1974 |
[The diabetic disease (M.D.). Clinical picture and complications].
Topics: Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Coma; Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Retinopathy; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Antibodies; Ketone Bodies; Radioimmunoassay; Tolbutamide | 1974 |
[Study of disorders of glycoregulation in the course of chronic hepatopathies of alcoholic origin].
Topics: Adrenal Cortex Hormones; Adult; Alcoholism; Chronic Disease; Diabetes Complications; Diuretics; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver Diseases; Male; Middle Aged; Obesity | 1967 |
Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic.
Topics: Adenoma, Islet Cell; Adult; Aged; Diabetes Complications; Diabetes Mellitus; Fluorescent Antibody Technique; Glucagon; Histocytochemistry; Humans; Hyperinsulinism; Immune Sera; Insulin; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Zollinger-Ellison Syndrome | 1969 |
[Lipoatrophic diabetes. Clinical and biological study of an atypical case].
Topics: Adipose Tissue; Adult; Biopsy; Blood Glucose; Diabetes Complications; Diabetic Neuropathies; Diabetic Retinopathy; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glycosuria, Renal; Humans; Insulin, Long-Acting; Lipodystrophy; Pituitary-Adrenal Function Tests; Skin; Steroids; Tolbutamide; Triglycerides | 1968 |
The hypoglycemias of childhood and their evaluation.
Topics: Adenoma, Islet Cell; Blood Glucose; Child; Child, Preschool; Deficiency Diseases; Diabetes Complications; Glucagon; Humans; Hypoglycemia; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Liver Diseases; Metabolism, Inborn Errors | 1971 |
Proceedings: Plasma levels of amino acids and glucagon in patients with pancreatic glucagonomas.
Topics: Adenoma, Islet Cell; Amino Acids; Anemia; Chromatography, Ion Exchange; Diabetes Complications; Diabetes Mellitus; Glucagon; Humans; Pancreatic Neoplasms; Radioimmunoassay; Skin Diseases; Syndrome | 1974 |
[Serum triglyceride changes in diabetes mellitus (pathogenetic and diagnostic significance)].
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Adult; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Epinephrine; Female; Glucagon; Glucose; Humans; Hypertension; Insulin; Lipid Metabolism; Liver; Male; Middle Aged; Triglycerides | 1973 |
Necrolytic migratory erythema with glucagon-secreting tumour of the pancreas.
Topics: Adenoma, Islet Cell; Amino Acids; Biopsy; Diabetes Complications; Erythema; Female; Glucagon; Humans; Male; Pancreas; Pancreatic Neoplasms; Skin; Tongue Diseases | 1974 |
Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aged; Blood Glucose; Chlorpropamide; Diabetes Complications; Female; Follicle Stimulating Hormone; Glucagon; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Hormones; Humans; Injections, Intravenous; Insulin; Luteinizing Hormone; Male; Middle Aged; Prolactin; Somatomedins; Thyrotropin | 1974 |
Abnormal pancreatic alpha-cell function in bacterial infections.
Topics: Adolescent; Adult; Animals; Bacterial Infections; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Dogs; Fever; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Pneumococcal Infections; Pneumonia | 1973 |
[Comparison of glucagon secretions in diabetes mellitus with or without acquired organic pancreatopathy].
Topics: Arginine; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Glucagon; Hemochromatosis; Humans; Insulin; Pancreatectomy; Pancreatic Diseases; Pancreatitis | 1973 |
End-stage diabetic nephropathy. Discussion: metabolic complications.
Topics: Adrenal Insufficiency; Animals; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Dogs; Glucagon; Glucose; Humans; Hypercalcemia; Hyperlipidemias; Hyperparathyroidism, Secondary; Insulin; Insulin Secretion; Kidney Transplantation; Metabolic Diseases; Nephrectomy; Nitrogen; Rats; Transplantation, Homologous | 1974 |
A role for glucagon during infection.
Topics: Animals; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Dogs; Fever; Glucagon; Glucose; Humans; Infections; Liver; Liver Glycogen | 1973 |
[Primary and secondary hyperinsulinism].
Topics: Acromegaly; Cushing Syndrome; Diabetes Complications; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Hyperthyroidism; Hypertrophy; Insulin; Islets of Langerhans; Liver Diseases; Pancreatic Diseases; Pancreatic Neoplasms; Postgastrectomy Syndromes; Tolbutamide | 1970 |
Clinical remission in diabetes mellitus. Studies of insulin secretion.
Topics: Acidosis; Acute Disease; Blood Glucose; Clinical Enzyme Tests; Diabetes Complications; Female; Glucagon; Glucose Oxidase; Glucose Tolerance Test; Humans; Hydroxybutyrates; Insulin; Insulin Secretion; Islets of Langerhans; Ketones; Middle Aged; Radioimmunoassay; Regeneration; Time Factors; Tolbutamide | 1970 |
Plasma insulin, glucagon, and nonesterified fatty acids in dogs with diabetes mellitus.
Topics: Acidosis; Age Factors; Animals; Antigens; Cattle; Diabetes Complications; Diabetes Mellitus; Dog Diseases; Dogs; Fatty Acids, Nonesterified; Female; Glucagon; Guinea Pigs; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Antibodies; Insulin Secretion; Male; Pancreas; Pancreatic Diseases; Radioimmunoassay | 1972 |
Metabolic and hormonal patterns after three days of total fasting in 27 obese and nonobese subjects.
Topics: Arginine; Blood Glucose; Depression, Chemical; Diabetes Complications; Diabetes Mellitus; Fasting; Glucagon; Growth Hormone; Humans; Insulin; Insulin Secretion; Obesity; Radioimmunoassay; Stimulation, Chemical; Time Factors | 1972 |
New light on carbohydrate disorders.
Topics: Carbohydrate Metabolism, Inborn Errors; Diabetes Complications; Diabetes Mellitus; Diabetic Coma; Galactosemias; Glucagon; Humans; Insulin; Insulin Secretion | 1969 |
[Glucagon and cardiogenic shock].
Topics: Aged; Diabetes Complications; Female; Glucagon; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Nausea; Prognosis; Shock, Cardiogenic | 1970 |
[Glucagon, the indispensable companion of the insulin injecting diabetic].
Topics: Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose; Humans; Hypoglycemia; Injections, Intramuscular; Injections, Intravenous; Insulin | 1967 |
Hypopituitarism and diabetes mellitus: effect of human growth hormone.
Topics: Blood Glucose; Body Weight; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Growth; Growth Hormone; Humans; Hypoglycemia; Hypopituitarism; Infant; Insulin; Male; Tolbutamide | 1968 |
Carbohydrate metabolism studies in cirrhosis of the liver.
Topics: Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Potassium Deficiency; Sulfobromophthalein; Tolbutamide; Uremia | 1968 |
[Diagnosis of pheochromocytomas].
Topics: Angiography; Catecholamines; Diabetes Complications; Glucagon; Histamine; Humans; Hypertension; Hyperthyroidism; Hypotension, Orthostatic; Injections, Intravenous; Methods; Paraganglioma; Paresthesia; Phentolamine; Pheochromocytoma; Retropneumoperitoneum; Tyramine; Urography | 1968 |
[On the cause and treatment of the senile diabetes].
Topics: Aged; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Diet Therapy; Exercise Therapy; Fatty Liver; Glucagon; Humans; Hypoglycemic Agents; Injections, Intramuscular; Insulin; Liver Glycogen; Obesity; Rabbits | 1968 |
Insulin response to glucagon. The opposing effects of diabetes and obesity.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Obesity; Stimulation, Chemical | 1969 |
Pancreatic A-cell tumor associated with severe diabetes mellitus.
Topics: Adult; Diabetes Complications; Female; Glucagon; Humans; Pancreatic Neoplasms | 1966 |
[Glucagon in hypoglycemic conditions].
Topics: Blood Glucose; Diabetes Complications; Glucagon; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Liver Function Tests; Shock | 1966 |
Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide.
Topics: Adult; Autoradiography; Biopsy; Diabetes Complications; Erythema; Glucagon-Like Peptides; Glucagonoma; Humans; Male; Pancreatic Neoplasms; Peptides; Skin; Thymidine; Tritium | 1982 |